Anesthesia Induction With Intravenous Bolus or Continuous Infusion of Remimazolam

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

November 25, 2022

Study Completion Date

November 25, 2022

Conditions
AdultAnesthesia, General
Interventions
DRUG

Bolus injection of remimazolam

Participants in this group are administered 0.2 mg/kg remimazolam via the bolus injection method for 20 seconds during anesthesia induction. If loss of consciousness (LOC) does not occur, the investigators will administer additional doses of 0.05 mg/kg repeatedly until LOC occurs.

DRUG

Infusion of remimazolam

Participants in this group are administered remimazolam at a rate of 6 mg/kg/hr via the continuous infusion method during anesthesia induction. If loss of consciousness (LOC) does not occur, the investigators will escalate infusion dose to 12 mg/kg/hr until LOC occurs.

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
collaborator

Hana Pharm Co., Ltd.

INDUSTRY

lead

Korea University Guro Hospital

OTHER